BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: MicroRNA-200 (miR-200)

September 10, 2015 7:00 AM UTC

In vitro studies suggest inhibiting miR-200 could help treat DNA damage-induced complications of Type I diabetes. Serum levels of miR-200 were higher in fibroblasts and induced pluripotent stem (iPS) ...